Endometrial cancer (EC) is the most common gynecological malignancy in developed countries, with its incidence steadily rising worldwide due to increasing ...

Pembrolizumab has robust, durable clinical benefit in patients with heavily pretreated CCGC and was tolerated in the overall population,” researchers wrote.

Two new measures tied to outcomes drawn from data in the CLEAR phase 3 trial will be presented during the ASCO Genitourinary ...

Uterine cancer occurs when cells in the uterus change and grow uncontrollably, forming a mass called a tumor. The exact cause of uterine cancer is not yet known; however, the following factors may ...

In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that short-course, higher dose vaginal brachytherapy for endometrial cancer had ...

Your doctor may prescribe one or more of the following treatments for platinum-resistant endometrial cancer. Chemotherapy involves the use of drugs to kill cancer cells. It may involve treatment ...

Endometrial cancer is the most commonly diagnosed gynecological cancer. Women with clear cell endometrial cancer, a rare type of endometrial cancer, generally have poorer clinical outcomes ...

Managing endometrial cancer can be very stressful. Taking steps to support your emotional and mental health is important for improving your quality of life with this condition. An endometrial ...